Financing

Proceeds from Borrowings on Revolving Credit Facility

Moderna Proceeds from Borrowings on Revolving Credit Facility remained flat by 0.0% to $150.00M in Q4 2025 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2023
Last reportedQ4 2025Feb 20, 2026
Metric ID: lrcx_proceeds_from_revolving_credit_facility

Historical Data

3 years
 FY'23FY'24FY'25
Value$0.00$0.00$600.00M
Range$0.00 – $600.00M

Frequently Asked Questions

What is Moderna's proceeds from borrowings on revolving credit facility?
Moderna (MRNA) reported proceeds from borrowings on revolving credit facility of $150.00M in Q4 2025.